Hence, impaired or abolished glymphatic/meningeal lymphatic waste clearance of the waste products may play a role in the pathophysiology of Alzheimer’s (soluble amyloid-β and tau) and Parkinson’s diseases (α-synuclein) [47]. This evidence concerns the gene MAPT and Parkinson disease.